Scinovex
article Open AccessTop 1% cited

RNA-programmed genome editing in human cells

eLife · 2013 · Vol. 2 · pp. e00471–e00471
Martin JínekAlexandra EastAaron ChengSteven LinEnbo MaJennifer A. Doudna

Abstract

Type II CRISPR immune systems in bacteria use a dual RNA-guided DNA endonuclease, Cas9, to cleave foreign DNA at specific sites. We show here that Cas9 assembles with hybrid guide RNAs in human cells and can induce the formation of double-strand DNA breaks (DSBs) at a site complementary to the guide RNA sequence in genomic DNA. This cleavage activity requires both Cas9 and the complementary binding of the guide RNA. Experiments using extracts from transfected cells show that RNA expression and/or assembly into Cas9 is the limiting factor for Cas9-mediated DNA cleavage. In addition, we find that extension of the RNA sequence at the 3' end enhances DNA targeting activity in vivo. These results show that RNA-programmed genome editing is a facile strategy for introducing site-specific genetic changes in human cells.DOI:http://dx.doi.org/10.7554/eLife.00471.001.

CRISPR and Genetic EngineeringCytomegalovirus and herpesvirus researchRNA Interference and Gene DeliveryCas9RNACRISPRGuide RNABiologyDNAGenome editingRNA editingComputational biologyRNA silencing

MeSH terms

HumansRNARNA EditingClustered Regularly Interspaced Short Palindromic Repeats

Funding

  • Howard Hughes Medical Institute
  • National Institutes of Health
Citations
2,139
FWCI
98.52
field-weighted impact
References
15
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.